By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...

BRAIN Biotech is contributing its proprietary bioleaching technology as the core technology for recovering of BioGold TM. The PX Urban Mining Initiative is open to additional partners who wish to ...

The expanded collaboration between BRAIN Biotech and PX Group is a key part of the PX Urban Mining Initiative, an industry and academic network focused on developing and implementing disruptive, ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 ...

Roses, carnations, pompons, hydrangeas, chrysanthemums and gypsophila arrive on hundreds of flights, mostly from Colombia and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

British Columbia is home to a thriving life sciences sector, with over 2,000 companies employing more than 20,000 people across the province. However, the lack of specialized research facilities in B.